US FDA Office Of New Drugs Reorg: Phase 3 Pushed To January

 
• By Michael McCaughan
  
reorganization
The OND reorganization remains on track for completion in February or March.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership